Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Other financing activities (2020 - 2023)

Historic Other financing activities for NeuroPace (NPCE) over the last 4 years, with Q4 2023 value amounting to $186000.0.

  • NeuroPace's Other financing activities fell 4639.77% to $186000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was $186000.0, marking a year-over-year decrease of 6008.58%. This contributed to the annual value of $305000.0 for FY2023, which is 1210.37% down from last year.
  • According to the latest figures from Q4 2023, NeuroPace's Other financing activities is $186000.0, which was down 4639.77% from $9000.0 recorded in Q2 2023.
  • NeuroPace's Other financing activities' 5-year high stood at $1.8 million during Q2 2021, with a 5-year trough of $9000.0 in Q2 2023.
  • For the 4-year period, NeuroPace's Other financing activities averaged around $554888.9, with its median value being $186000.0 (2023).
  • Per our database at Business Quant, NeuroPace's Other financing activities surged by 144700.85% in 2021 and then tumbled by 4639.77% in 2023.
  • NeuroPace's Other financing activities (Quarter) stood at $96000.0 in 2020, then soared by 1785.42% to $1.8 million in 2021, then crashed by 80.83% to $347000.0 in 2022, then crashed by 46.4% to $186000.0 in 2023.
  • Its last three reported values are $186000.0 in Q4 2023, $9000.0 for Q2 2023, and $110000.0 during Q1 2023.